cometadata/datacite-rtg-text-other-reclassification-records huggingface dataset:
Cotysoides guangxiensis Zheng & Jiang 2000
Creators: name: Deng, Wei-An
name: Zheng, Zhe-Min
name: Li, Xiao-Dong
name: Lin, Min-Ping
name: Wei, Shi-Zhen
name: Yuan, Bao-Dong
name: Lin, Li-Liang
Publisher: name: Zenodo
Year: 2015
Subjects: Biodiversity
Taxonomy

description: 32. Cotysoides guangxiensis Zheng & Jiang, 2000
Specimens examined. 3 ♂ 2♀, Shangsi (Hualan), 21°55’N, 107°49’E, 400m alt, 15 Aug. 2012, collected by Wei- An DENG.
Distribution. China (Guangxi).
description: Published as part of Deng, Wei-An, Zheng, Zhe-Min, Li, Xiao-Dong, Lin, Min-Ping, Wei, Shi-Zhen, Yuan, Bao-Dong & Lin, Li-Liang, 2015, The groundhopper fauna (Orthoptera: Tetrigidae) of Shiwanshan (Guangxi, China) with description of three new species, pp. 151-178 in Zootaxa 3925 (2) on page 158, DOI: 10.11646/zootaxa.3925.2.1, http://zenodo.org/record/243557
RAQAMLI IQTISODIYOTDA AXBOROT TEXNOLOGIYALARIDAN FOYDALANISHNING DOLZARBLIGI
Creators: name: Qodirov, Farrux
name: Saidova, Mohinur
Publisher: name: Zenodo
Year: 2024

description: Ushbu maqolada raqamli iqtisodiyot va raqamli iqtisodiyotda axborot texnologiyalaridan foydalanishni muhimligi,global iqtisodiyotdagi o’rni haqida va nojo’ya ta’sirlari va ularni bartaraf etish haqida fikr yuritiladi.
Additional file 6: Figure S6. of Radical Scavenging Activities of Lagerstroemia speciosa (L.) Pers. Petal Extracts and its hepato-protection in CCl4-intoxicated mice
Creators: name: Bipransh Tiwary
name: Somit Dutta
name: Priyankar Dey
name: Mossaraf Hossain
name: Anoop Kumar
name: Sony Bihani
name: Ashis Nanda
name: Chaudhuri, Tapas
name: Ranadhir Chakraborty
Publisher: name: Figshare
Year: 2017
Subjects: subject: Biochemistry
subject: Molecular Biology
subject: 59999 Environmental Sciences not elsewhere classified
subject: FOS: Earth and related environmental sciences
subject: 39999 Chemical Sciences not elsewhere classified
subject: FOS: Chemical sciences
subject: 69999 Biological Sciences not elsewhere classified
subject: FOS: Biological sciences
subject: Developmental Biology
subject: Cancer
subject: Plant Biology
subject: 60506 Virology

description: EDS spectra of ethanolic flower extract of Lagerstroemia speciosa (DOCX 58 kb)
Low surface brightness galaxies from BASS+MzLS with Machine Learning
Creators: name: Du, Peng-Liang
name: Du, Wei
name: Zhang, Bing-Qing
name: Yi, Zhen-Ping
name: He, Min
name: Wu, Hong
Publisher: name: arXiv
Year: 2024
Subjects: subject: Astrophysics of Galaxies (astro-ph.GA)
subject: FOS: Physical sciences

description: From $\sim$ 5000 deg$^{2}$ of the combination of the Beijing-Arizona Sky Survey (BASS) and Mayall $z$-band Legacy Survey (MzLS) which is also the northern sky region of the Dark Energy Spectroscopic Instrument (DESI) Legacy Imaging Surveys, we selected a sample of 31,825 candidates of low surface brightness galaxies (LSBGs) with the mean effective surface brightness 24.2 $< \barμ_{\rm eff,g} <$ 28.8 mag arcsec$^{\rm -2}$ and the half-light radius 2.5$^{\prime\prime}$ $< r_{\rm eff} <$ 20$^{\prime\prime}$ based on the released photometric catalogue and the machine learning model. The distribution of the LSBGs is of bimodality in the $g$ - $r$ color, indicating the two distinct populations of the blue ($g$ - $r <$ 0.60) and the red ($g$ - $r >$ 0.60) LSBGs. The blue LSBGs appear spiral, disk or irregular while the red LSBGs are spheroidal or ellipitcal and spatially clustered. This trend shows that the color has a strong correlation with galaxy morphology for LSBGs. In the spatial distribution, the blue LSBGs are more uniformly distributed while the red ones are highly clustered, indicating that red LSBGs preferentially populated denser environment than the blue LSBGs. Besides, both populations have consistent distribution of ellipticity (median $ε\sim$ 0.3), half-light radius (median $r_{\rm eff} \sim$ 4$^{\prime\prime}$), and Sersic index (median $n$ = 1), implying the dominance of the full sample by the round and disk galaxies. This sample has definitely extended the studies of LSBGs to a regime of lower surface brightness, fainter magnitude, and broader other properties than the previously SDSS-based samples.
description: 20 pages, 11 figures, 1 table, accepted by Research in Astronomy and Astrophysics
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer
Creators: name: Bestvina, Christine M.
name: Waters, Dexter
name: Morrison, Laura
name: Emond, Bruno
name: Lafeuille, Marie-Hélène
name: Hilts, Annalise
name: Lefebvre, Patrick
name: He, Andy
name: Vanderpoel, Julie
Publisher: name: Taylor & Francis
Year: 2024
Subjects: subject: Medicine
subject: Genetics
subject: FOS: Biological sciences
subject: Biological Sciences not elsewhere classified
subject: Cancer
subject: Science Policy
subject: Infectious Diseases
subject: FOS: Health sciences

description: To assess US payers’ per-patient cost of testing associated with next-generation sequencing (NGS) versus polymerase chain reaction (PCR) biomarker testing strategies among patients with metastatic non-small cell lung cancer (mNSCLC), including costs of testing, delayed care, and suboptimal treatment initiation. A decision tree model considered biomarker testing for genomic alterations using either NGS, sequential PCR testing, or hotspot panel PCR testing. Literature-based model inputs included time-to-test results, costs for testing/medical care, costs of delaying care, costs of immunotherapy [IO]/chemotherapy [CTX] initiation prior to receiving test results, and costs of suboptimal treatment initiation after test results (i.e. costs of first-line IO/CTX in patients with actionable mutations that were undetected by PCR that would have been identified with NGS). The proportion of patients testing positive for a targetable alteration, time to appropriate therapy initiation, and per-patient costs were estimated for NGS and PCR strategies combined. In a modeled cohort of 1,000,000 members (25% Medicare, 75% commercial), an estimated 1,119 had mNSCLC and received testing. The proportion of patients testing positive for a targetable alteration was 45.9% for NGS and 40.0% for PCR testing. Mean per-patient costs were lowest for NGS ($8,866) compared to PCR ($18,246), with lower delayed care costs of $1,301 for NGS compared to $3,228 for PCR, and lower costs of IO/CTX initiation prior to receiving test results (NGS: $2,298; PCR:$5,991). Cost savings, reaching $10,496,220 at the 1,000,000-member plan level, were driven by more rapid treatment with appropriate therapy for patients tested with NGS (2.1 weeks) compared to PCR strategies (5.2 weeks). Model inputs/assumptions were based on published literature or expert opinion. NGS testing was associated with greater cost savings versus PCR, driven by more rapid results, shorter time to appropriate therapy initiation, and minimized use of inappropriate therapies while awaiting and after test results.
Macromotettix serrifemoralis Zheng & Jiang 2002
Creators: name: Deng, Wei-An
name: Zheng, Zhe-Min
name: Li, Xiao-Dong
name: Lin, Min-Ping
name: Wei, Shi-Zhen
name: Yuan, Bao-Dong
name: Lin, Li-Liang
Publisher: name: Zenodo
Year: 2015
Subjects: Biodiversity
Taxonomy

description: 33. Macromotettix serrifemoralis Zheng & Jiang, 2002
Specimens examined. 2 ♂ 2♀, Fangcheng (Dalu), 21°53’N, 108°02’E, 400m alt, 7 Aug. 2012, collected by Li- Liang LIN.
Distribution. China (Guangxi).
description: Published as part of Deng, Wei-An, Zheng, Zhe-Min, Li, Xiao-Dong, Lin, Min-Ping, Wei, Shi-Zhen, Yuan, Bao-Dong & Lin, Li-Liang, 2015, The groundhopper fauna (Orthoptera: Tetrigidae) of Shiwanshan (Guangxi, China) with description of three new species, pp. 151-178 in Zootaxa 3925 (2) on page 158, DOI: 10.11646/zootaxa.3925.2.1, http://zenodo.org/record/243557
Scambus gallicerator Kasparyan 1974
Creators: name: Varga, Oleksandr
Publisher: name: Zenodo
Year: 2019
Subjects: Biodiversity
Taxonomy
Animalia
Arthropoda
Insecta
Hymenoptera
Ichneumonidae
Scambus
Scambus gallicerator

description: Scambus gallicerator Kasparyan, 1974 (Fig. 13)
Records. New record.
Material examined. Donetsk Reg.: 1 ♀, Kamyani Mohyly Reserve, SN, 25–27.v.2009, leg. S. Simutnik.
Distribution. Palaearctic; Ukraine: Donetsk Reg.
Biology. PS. May.
description: Published as part of Varga, Oleksandr, 2019, Taxonomy and distribution of pimpline parasitoids (Hymenoptera, Ichneumonidae, Pimplinae) in Ukraine, pp. 1-65 in Zootaxa 4693 (1) on page 35, DOI: 10.11646/zootaxa.4693.1.1, http://zenodo.org/record/3529018
Value of Next Generation Sequencing (NGS) testing in advanced cancer patients
Creators: name: Ortendahl, Jesse D.
name: Carter, Gebra Cuyun
name: Thakkar, Snehal G.
name: Bognar, Katalin
name: Hall, David W.
name: Abdou, Yara
Publisher: name: Taylor & Francis
Year: 2024
Subjects: Medicine
Biological Sciences not elsewhere classified
Cancer
Science Policy

description: Aims: The availability of targeted therapies for oncology patients is increasing. Available genomic tests to identify treatment-eligible patients include single gene tests and gene panel tests, including the whole-exome, whole-transcriptome OncoExTraTM test. We assessed the costs and clinical benefits of test choice. Methods: A Microsoft Excel-based model was developed to evaluate test choice in patients with advanced/metastatic non-small cell lung cancer (NSCLC), breast, prostate, and colorectal cancer. Treatment pathways were based on NCCN guidelines and medical expert opinion. Inputs were derived from published literature. Annual economic results and lifetime clinical results with OncoExTra testing were projected per-tested-patient and compared with single gene testing and no testing. Separately, results were estimated for a US health plan without the OncoExTra test and with its use in 5% of patients. Results: Compared with no genomic testing, OncoExTra test use increased costs by $4,915 per patient; however, 82%-92% of individuals across tumor types were identified as eligible for targeted therapy or a clinical trial. Compared with single gene testing, OncoExTra test use decreased costs by $9,966 per-patient-tested while increasing use of approved or investigational targeted therapies by 20%. When considering a hypothetical health plan with 1 million members, 858 patients were eligible for genomic testing. Using the OncoExTra test in 5% of those eligible, per-member per-month costs decreased by $0.003, ranging from cost-savings of $0.026 in NSCLC patients to a $0.009 increase in prostate cancer patients. Cost-savings were driven by reduced treatment costs with increased clinical trial enrollment and reduced direct and indirect medical costs associated with targeted treatments. Conclusions: Limitations include the required simplifications in modeling complex conditions that may not fully reflect evolving real-world testing and treatment patterns. Compared to single-gene testing, results indicate that using NGS test such as OncoExTra identified more actionable alterations, leading to improved outcomes and reduced costs.
title: Communication and Listening as the Methods of Collaborative Partnerships with, Child’s Parents, Early Childhood Teacher and Early Childhood Children
Creators: name: Noppamast Sae-Tang
Publisher: name: Thonburi University
publisherIdentifierScheme: ROR
Year: 2025
Subjects: Child’s parents
Collaborative Partnerships
Communication and Listening
Early Childhood Teacher

description: Journal of Humanities and Social Sciences Thonburi University, 19, 1, 191-202
Additional file 6: Figure S6. of Radical Scavenging Activities of Lagerstroemia speciosa (L.) Pers. Petal Extracts and its hepato-protection in CCl4-intoxicated mice
Creators: name: Bipransh Tiwary
name: Somit Dutta
name: Priyankar Dey
name: Mossaraf Hossain
name: Anoop Kumar
name: Sony Bihani
name: Ashis Nanda
name: Chaudhuri, Tapas
name: Ranadhir Chakraborty
Publisher: name: Figshare
Year: 2017
Subjects: subject: Biochemistry
subject: Molecular Biology
subject: 59999 Environmental Sciences not elsewhere classified
subject: FOS: Earth and related environmental sciences
subject: 39999 Chemical Sciences not elsewhere classified
subject: FOS: Chemical sciences
subject: 69999 Biological Sciences not elsewhere classified
subject: FOS: Biological sciences
subject: Developmental Biology
subject: Cancer
subject: Plant Biology
subject: Virology

description: EDS spectra of ethanolic flower extract of Lagerstroemia speciosa (DOCX 58 kb)
Mazarredia Bolivar 1887
Creators: name: Deng, Wei-An
name: Zheng, Zhe-Min
name: Li, Xiao-Dong
name: Lin, Min-Ping
name: Wei, Shi-Zhen
name: Yuan, Bao-Dong
name: Lin, Li-Liang
Publisher: name: Zenodo
Year: 2015
Subjects: Biodiversity
Taxonomy
Animalia
Arthropoda
Insecta
Orthoptera
Tetrigidae
Mazarredia

description: Genus Mazarredia Bolivar, 1887
Description. Body moderate-sized or small, slender. Head distinctly exserted above the pronotal surface, vertex generally as broad as or narrower than an eye, median carinula distinct anteriorly. In profile, frontal costa arcuate between antennae. Antennae filiform, inserted between the lower margins of eyes. Eyes globular in shape, Eyes strongly exserted above the pronotal surface, paired ocelli placed between above the lower margins of the eyes. Disc of pronotum smooth, concave behind shoulders. Pronotum elongate, extending far beyond the top of hind femora. Lateral lobes of pronotum produced outwards, end of posterior angles truncate, posterior margins of lateral lobes of pronotum with two concavities. Tegmina long oval, apex round. Hind wings developed. Anterior and middle femora elongated, margins straight or slightly undulated, posterior femora normal, first and third posterior tarsal segments nearly equal in length.
Mazarredia Bolívar is similar to Macromotettix Günther from which it differs in humeral apex ridge and lower margin of pronotum connected before middle of lower margin of pronotum (humeral apex ridge and lower margin of pronotum connected in the middle or behind middle of lower margin of pronotum in Macromotettix).
description: Published as part of Deng, Wei-An, Zheng, Zhe-Min, Li, Xiao-Dong, Lin, Min-Ping, Wei, Shi-Zhen, Yuan, Bao-Dong & Lin, Li-Liang, 2015, The groundhopper fauna (Orthoptera: Tetrigidae) of Shiwanshan (Guangxi, China) with description of three new species, pp. 151-178 in Zootaxa 3925 (2) on pages 158-159, DOI: 10.11646/zootaxa.3925.2.1, http://zenodo.org/record/243557
Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population
Creators: name: Alvarez, F. P.
name: Allard, L.
name: Bianic, F.
name: Bricout, H.
name: Crépey, P.
name: Gaillat, J.
name: Gavazzi, G.
name: Mosnier, A.
name: Launay, O.
name: Levant, M. C.
name: Proshenska, D.
name: de Courville, C.
Publisher: name: Taylor & Francis
Year: 2024
Subjects: subject: Medicine
subject: Sociology
subject: FOS: Sociology
subject: Biological Sciences not elsewhere classified
subject: Science Policy
subject: Infectious Diseases
subject: FOS: Health sciences
subject: Virology

description: Seasonal influenza outbreaks in France cause a surge in patients, exacerbating the overburdened healthcare system each winter. Older adults are particularly vulnerable to serious events related to influenza. Quadrivalent influenza high dose (QIV HD) vaccines have been developed to offer better clinical protection in older adults, who often exhibit suboptimal immune response to quadrivalent influenza standard dose vaccines (QIV SD). This study aims to evaluate the public health impact and cost-effectiveness of administering HD versus SD vaccines to individuals aged 65+ in France. Using a static model and decision-tree approach, the study analyzed health outcomes such as influenza cases, GP (general practitioner) visits, hospitalizations, and mortality; relative vaccine efficacy (rVE) estimates were derived from a pivotal randomized-controlled trial and a meta-analysis comparing HD to SD vaccines. Two approaches were implemented to model hospitalizations (conditional on influenza or not), and analyses on bed occupancy were performed. Results showed that using QIV HD instead of QIV SD during an average influenza season in France led to the prevention of 57,209 additional cases of influenza, 13,704 GP visits, and 764 influenza-related deaths. Moreover, switching to QIV HD resulted in an additional 1,728–15,970 hospitalizations avoided and 15,124–138,367 reduced days of hospitalization depending on the hospitalization approach used. The cost-utility analysis showed a cost per quality-adjusted life year (QALY) gained ranging from 24,020 €/QALY to 5,036 €/QALY. Switching to QIV HD in older adults was shown to be cost-effective, with even greater public health benefits at a higher coverage rate, regardless of the season severity.
Multisensor Data Fusion for Automatized Insect Monitoring (KInsecta)
Creators: name: Tschaikner, Martin
name: Brandt, Danja
name: Schmidt, Henning
name: Bießmann, Felix
name: Chiaburu, Teodor
name: Schrimpf, Ilona
name: Schrimpf, Thomas
name: Stadel, Alexandra
name: Haußer, Frank
name: Beckers, Ingeborg
Publisher: name: arXiv
Year: 2024
Subjects: subject: Machine Learning (cs.LG)
subject: Computer Vision and Pattern Recognition (cs.CV)
subject: Signal Processing (eess.SP)
subject: FOS: Computer and information sciences
subject: FOS: Electrical engineering, electronic engineering, information engineering

description: Insect populations are declining globally, making systematic monitoring essential for conservation. Most classical methods involve death traps and counter insect conservation. This paper presents a multisensor approach that uses AI-based data fusion for insect classification. The system is designed as low-cost setup and consists of a camera module and an optical wing beat sensor as well as environmental sensors to measure temperature, irradiance or daytime as prior information. The system has been tested in the laboratory and in the field. First tests on a small very unbalanced data set with 7 species show promising results for species classification. The multisensor system will support biodiversity and agriculture studies.
Mazarredia huanjiangensis Zheng & Jiang 1994
Creators: name: Deng, Wei-An
name: Zheng, Zhe-Min
name: Li, Xiao-Dong
name: Lin, Min-Ping
name: Wei, Shi-Zhen
name: Yuan, Bao-Dong
name: Lin, Li-Liang
Publisher: name: Zenodo
Year: 2015
Subjects: Biodiversity
Taxonomy

description: 34. Mazarredia huanjiangensis Zheng & Jiang, 1994
Specimens examined. 3 ♂ 2♀, Fangcheng (Dalu), 21°53’N, 108°02’E, 500m alt, 15 Aug. 2012, collected by Li- Liang LIN.
Distribution. China (Guangxi).
description: Published as part of Deng, Wei-An, Zheng, Zhe-Min, Li, Xiao-Dong, Lin, Min-Ping, Wei, Shi-Zhen, Yuan, Bao-Dong & Lin, Li-Liang, 2015, The groundhopper fauna (Orthoptera: Tetrigidae) of Shiwanshan (Guangxi, China) with description of three new species, pp. 151-178 in Zootaxa 3925 (2) on page 159, DOI: 10.11646/zootaxa.3925.2.1, http://zenodo.org/record/243557
Analysis of factors associated with premiums for reimbursed medical devices in Japan
Creators: name: LoPresti, Michael
name: Igarashi, Ataru
Publisher: name: Taylor & Francis
Year: 2024
Subjects: subject: Space Science
subject: Medicine
subject: Biotechnology
subject: Evolutionary Biology
subject: FOS: Biological sciences
subject: Biological Sciences not elsewhere classified
subject: Science Policy
subject: Computational Biology

description: The aim of this study is to examine factors that relate to receipt of a reimbursement premium in Japan, which is defined as an increase in the initially calculated reimbursement price based on certain criteria, or an increase in the operating profit ratio. Reimbursement submissions and decisions for newly reimbursed medical devices in Japan from fiscal year (FY) 2015 to FY 2023 were reviewed to consider their characteristics. Moreover, the relationship between reimbursement submission characteristics, as well as other characteristics such as regulatory submission category, risk class, location of the manufacturer headquarters, etc. and the receipt of a Novelty, Usefulness, or Improvement premium (hereafter “utility premium”), or an increase in the operating profit ratio, was examined using univariate and multivariate regression. Among 131 unique medical devices newly reimbursed in Japan from FY 2015 to FY 2023, 57 devices (44%) received a reimbursement premium. Among those, 30 devices (53%) were devices to treat cardiovascular conditions. Based on univariate regression, therapy area, reimbursement category and method used, duration since the comparator device was listed, and estimated peak annual patients for the new device are factors that affect the receipt of a utility premium or an increase in the operating profit ratio. However, based on multivariate regression, only the therapy area, risk-related regulatory submission class, regulatory submission type (novelty), and orphan device designation are associated with the receipt of a utility premium or an increase in the operating profit ratio. Receipt of a utility premium can be challenging. Moreover, medical devices to treat cardiovascular conditions have benefited more from premiums. This may be due to those devices having more data on efficacy at the time of approval and listing. More opportunities for devices to obtain premiums following initial listing may be needed to adequately capture their value.
Biocontrol of plant pathogens by Lysobacter enzymogenes isolate LEC: efficacy of shake flask broth, fermentation broth and dried preparations
Creators: name: Drenker, Christian
name: Mazouar, Doris El
name: Seib, Tanja
name: Weißhaupt, Sonja
name: Stephan, Dietrich
name: Kunz, Stefan
name: Reineke, Annette
name: Rondot, Yvonne
name: Linkies, Ada
name: Koch, Eckhard
Publisher: name: Taylor & Francis
Year: 2024
Subjects: subject: Space Science
subject: Microbiology
subject: FOS: Biological sciences
subject: Cell Biology
subject: Genetics
subject: Biotechnology
subject: Ecology
subject: Biological Sciences not elsewhere classified
subject: Infectious Diseases
subject: FOS: Health sciences

description: The aim of our study was to upscale the production of Lysobacter enzymogenes strain LEC from shake flasks to a laboratory bioreactor. The obtained fermentation broth was to be downstream-processed by lyophilisation and fluidised bed-drying, followed by testing of the dried preparations against plant pathogens. Different batches of broth from shake flasks and from individual fermenter runs were characterised and compared. Number of viable cells, in vitro efficacy (ED90 value) against the apple scab pathogen Ventura inaequalis, as well as efficacy against Phytophthora infestans on potato plants were all reproducible and not impaired by upscaling the production volume from shake flask to the bioreactor. Fermentation broth was processed by lyophilisation and fluidised bed-drying. In bioassays, the activity against downy mildew (Pseudoperonospora cubensis) on cucumber were comparable for the unformulated fermentation broth and the fluidised bed-dried product, while the lyophilised product was significantly more effective. Strain LEC showed reproducible pathogen suppressive activity, independent from production scale and batch. Production upscaling and formulation by drying are possible without loss of efficacy.
Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data
Creators: name: Niegisch, Günter
name: Grimm, Marc-Oliver
name: Hardtstock, Fraence
name: Krieger, Julia
name: Starry, Alexandra
name: Osowski, Ulrike
name: Deiters, Barthold
name: Maywald, Ulf
name: Wilke, Thomas
name: Kearney, Mairead
Publisher: name: Taylor & Francis
Year: 2024
Subjects: subject: Medicine
subject: Chemical Sciences not elsewhere classified
subject: Immunology
subject: FOS: Clinical medicine
subject: Cancer
subject: Science Policy

description: This retrospective claims data study characterized real-world treatment patterns, healthcare resource utilization (HCRU), and costs in patients with metastatic urothelial carcinoma (mUC) in Germany. Continuously insured adults with incident mUC diagnosis (=index; ICD-10: C65–C68/C77–C79) in 2015–2019 were identified from two German claims databases. Patients who received first-line (1 L) treatment within 12 months of index were divided into three mutually exclusive sub-cohorts: platinum-based chemotherapy (PB-CT), non–PB-CT, and immunotherapy (IO). Patient characteristics were assessed during a 24-month baseline period; treatments, HCRU, and costs (of the health insurance fund) per patient-year (ppy) were described during 12-month follow-up. We identified 3,226 patients with mUC (mean age, 73.8 years; male, 70.8%; mean Elixhauser Comorbidity Index, 17.6); 1,286 (39.9%) received 1 L treatment within 12 months of index. Of these, 825 (64.2%) received PB-CT, 322 (25.0%) non–PB-CT, and 139 (10.8%) IO. On average, treated patients had 5.1 hospitalizations ppy. Most UC-related hospitalizations ppy were observed in the PB-CT cohort (5.8), followed by the non–PB-CT (4.2) and IO (2.3) cohorts. Mean UC-related hospitalization costs ppy were €22,218 in the treated cohort, €24,294 in PB-CT, €19,079 in IO, and €18,530 in non–PB-CT cohorts. Cancer-related prescription costs ppy averaged €6,323 in treated patients, and €25,955 in IO, €4,318 in non–PB-CT, and €4,270 in PB-CT cohorts. We recognized limitations in our study’s sample selection due to unavailable mUC disease status data. We addressed this through an upstream feasibility study conducted in consultation with clinical experts to determine a suitable proxy. Proxies were also used to delineate treatment lines, switches, and discontinuations due to data absence. Furthermore, due to data restrictions, collective dataset analysis was not possible, prompting a meta-analysis for pooled results. The study shows that mUC is associated with significant HCRU and costs across different types of 1 L systemic therapy.
title: แนวทางการพัฒนาความฉลาดรู้การอ่านของนักเรียนชั้นมัธยมศึกษาปีที่ 1 โดยใช้การจัดการเรียนรู้แบบ KWL-Plus ร่วมกับข้อมูลท้องถิ่น จังหวัดปทุมธานี
Creators: name: สุภัชฌาน์  ศรีเอี่ยม
Publisher: name: Thonburi University
publisherIdentifierScheme: ROR
Year: 2025
Subjects: ความฉลาดรู้การอ่าน
การจัดการเรียนรู้แบบ KWL-Plus
ข้อมูลท้องถิ่นจังหวัดปทุมธานี
นักเรียนชั้นมัธยมศึกษาปีที่ 1

description: Journal of Humanities and Social Sciences Thonburi University, 19, 1, 203-214
Additional file 1: Table S1. of High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12Â months after resection
Creators: name: Felden, Johann Von
name: Heim, Denise
name: Schulze, Kornelius
name: Krech, Till
name: Ewald, Florian
name: BjĂśrn Nashan
name: Lohse, Ansgar
name: Wege, Henning
Publisher: name: Figshare
Year: 2017
Subjects: subject: Medicine
subject: Genetics
subject: FOS: Biological sciences
subject: Molecular Biology
subject: Sociology
subject: FOS: Sociology
subject: 69999 Biological Sciences not elsewhere classified
subject: Cancer

description: Cox Regression analysis subgroup T1 or T2. Table S2. Sequences of target miRNAs used in qPCR analysis. Figure S1. Kaplan-Meier curve subgroup analysis T1 and T2 tumors. Recurrence free survival (RFS) of patients with T1 and T2 tumor status stratified by high vs. low expression of miR-135a in HCC tissue. Cox regression p=0.146, n=16. Abbreviations: HR, hazard ratio; CI, confidence interval. (DOCX 237 kb)
Mazarredia nigripennis Deng, Zheng & Wei 2007
Creators: name: Deng, Wei-An
name: Zheng, Zhe-Min
name: Li, Xiao-Dong
name: Lin, Min-Ping
name: Wei, Shi-Zhen
name: Yuan, Bao-Dong
name: Lin, Li-Liang
Publisher: name: Zenodo
Year: 2015
Subjects: Biodiversity
Taxonomy

description: 35. Mazarredia nigripennis Deng, Zheng & Wei, 2007
Specimens examined. 2 ♂ 3♀, Fangcheng (Dalu), 21°53’N, 108°02’E, 500m alt, 16 Aug. 2012, collected by Li- Liang LIN.
Distribution. China (Guangxi).
description: Published as part of Deng, Wei-An, Zheng, Zhe-Min, Li, Xiao-Dong, Lin, Min-Ping, Wei, Shi-Zhen, Yuan, Bao-Dong & Lin, Li-Liang, 2015, The groundhopper fauna (Orthoptera: Tetrigidae) of Shiwanshan (Guangxi, China) with description of three new species, pp. 151-178 in Zootaxa 3925 (2) on page 159, DOI: 10.11646/zootaxa.3925.2.1, http://zenodo.org/record/243557
Oberschwäbische Gletscher- und Schmelzwasserbildungen im Vergleich mit rezenten Beispielen aus Alaska und der Arktis
Creators: name: German, Rüdiger
Publisher: name: - NO PUBLISHER DEFINED -
Year: 1995

description: Jahreshefte der Gesellschaft für Naturkunde in Württemberg
description: Bd. 151, 1995
Neue Grabungen im Nusplinger Plattenkalk (Weißer Jura, Ober-Kimmeridgium) der südwestlichen Schwäbischen Alb - ein Zwischenbericht
Creators: name: Dietl, Gerd
name: Kapitzke, Martin
name: Rieter, Markus
Publisher: name: - NO PUBLISHER DEFINED -
Year: 1995

description: Jahreshefte der Gesellschaft für Naturkunde in Württemberg
description: Bd. 151, 1995
Die quartären Sauerwasserkalke von Stuttgart - eine mikrofazielle Studie. (Walter-Schall-Preis 1994)
Creators: name: Koban, Christoph G.
Publisher: name: - NO PUBLISHER DEFINED -
Year: 1995

description: Jahreshefte der Gesellschaft für Naturkunde in Württemberg
description: Bd. 151, 1995
Additional file 1: of Using medical specialty and selection criteria clusters to study specialty selection by Israeli medical students
Creators: name: Weiss, Yoram
name: Zisk-Rony, Rachel
name: Tandeter, Howard
name: Elchalal, Uriel
name: Avidan, Alex
name: Schroeder, Josh
name: Weissman, Charles
Publisher: name: Figshare
Year: 2017
Subjects: subject: Medicine
subject: Evolutionary Biology
subject: FOS: Biological sciences
subject: Sociology
subject: FOS: Sociology
subject: 69999 Biological Sciences not elsewhere classified
subject: Science Policy

description: Appendix A â   Questionnaire. (DOC 94Â kb)
Cost-effectiveness analysis of budesonide/formoterol SMART therapy versus salmeterol/fluticasone plus as-needed SABA among patients ≥12 years with moderate asthma from the Chinese societal perspective
Creators: name: Zhou, Keruo
name: Zhang, Min
name: Zuo, Chenyu
name: Xie, Xiazhen
name: Xuan, Jianwei
Publisher: name: Taylor & Francis
Year: 2024
Subjects: subject: Medicine
subject: Pharmacology
subject: Sociology
subject: FOS: Sociology
subject: Biological Sciences not elsewhere classified
subject: Science Policy
subject: Infectious Diseases
subject: FOS: Health sciences

description: To evaluate the cost-effectiveness of budesonide/formoterol reliever and maintenance therapy compared with salmeterol/fluticasone plus salbutamol as reliever therapy for asthma patients ≥12 years from the societal perspective in China. A Markov model was developed with three health states (non-exacerbation, exacerbation, and death) with a lifetime horizon. The exacerbation rates were obtained from a prospective cohort study conducted in Chinese asthma patients. Healthcare resources utilization data were estimated based on current clinical asthma management guidelines. Asthma-related mortality, cost input and utility values were derived from public database and literature. Model robustness was assessed with one-way sensitivity and probabilistic sensitivity analyses. Compared with salmeterol/fluticasone plus salbutamol, budesonide/formoterol reliever and maintenance therapy led to fewer exacerbation events (13.6 vs. 15.9) and 0.0077 quality-adjusted life years (QALY) gain at an additional cost of ¥196.38 over lifetime. The base case incremental cost-effectiveness ratio (ICER) was ¥25,409.98 per QALY gained. The variables that had most impact on the model output included drug costs and medication adherence. At a willingness-to-pay threshold of ¥257,094/QALY (3 times of gross domestic product per capita in China in 2022), the probability of budesonide/formoterol maintenance and reliever therapy being cost-effective versus salmeterol/fluticasone plus as-needed salbutamol was 83.00%. From the societal perspective, budesonide/formoterol reliever and maintenance therapy is likely to be a cost-effective option compared with salmeterol/fluticasone plus as-needed salbutamol for Chinese asthma patients ≥12 years.
Zum Auftreten der Ammonitenarten Amoeboceras bauhini (OPPEL) und Amoeboceras schulginae MESEZHNIKOV im Oberjura der Schwäbischen Alb
Creators: name: Schweigert, Günter
Publisher: name: - NO PUBLISHER DEFINED -
Year: 1995

description: Jahreshefte der Gesellschaft für Naturkunde in Württemberg
description: Bd. 151, 1995
Rapport d'activité en bref 2023 des BU de l'UPHF
Creators: name: Oustlant, Christopher
name: Université Polytechnique Hauts-de-France
Publisher: name: Zenodo
Year: 2024
Subjects: Rapport d'activité
Pilotage

description: Rapport d'activité en bref du Service Commun de la Documentation de l'Université Polytechnique Hauts-de-France pour l'année 2023.
title: Completions and algebraic formulas for the coefficients of Ramanujan’s mock theta functions
Creators: name: Klein, David
name: Kupka, Jennifer
Publisher: name: Springer Science
Year: 2024

description: We present completions of mock theta functions to harmonic weak Maass forms of weight 1/2 and algebraic formulas for the coefficients of mock theta functions. We give several harmonic weak Maass forms of weight 1/2 that have mock theta functions as their holomorphic part. Using these harmonic weak Maass forms and the Millson theta lift, we compute finite algebraic formulas for the coefficients of the appearing mock theta functions in terms of traces of singular moduli.
Die seltenen Pflanzen des Böblinger Panzerplatzes unter der besonderer Berücksichtigung der Zwergbinsengesellschaften
Creators: name: Baumann, Helmut
name: Wahrenburg, Wolfram
Publisher: name: - NO PUBLISHER DEFINED -
Year: 1995

description: Jahreshefte der Gesellschaft für Naturkunde in Württemberg
description: Bd. 151, 1995
Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis
Creators: name: Isla, Dolores
name: Álvarez, Rosa
name: Arnal, María
name: Arriola, Edurne
name: Azkarate, Aitor
name: Azkona, Eider
name: García-Campelo, Rosario
name: Garrido, Pilar
name: Nadal, Ernest
name: Ortega, Ana L.
name: Carcedo, David
name: Crespo, María
name: Lavara, Jesús
name: Córcoles, Fernando
name: Bernabé, Reyes
Publisher: name: Taylor & Francis
Year: 2024
Subjects: subject: Medicine
subject: Microbiology
subject: FOS: Biological sciences
subject: Genetics
subject: Pharmacology
subject: Biotechnology
subject: Sociology
subject: FOS: Sociology
subject: Biological Sciences not elsewhere classified
subject: Cancer
subject: Science Policy

description: Liquid biopsy (LB) is a non-invasive technique to detect genetic alterations by next-generation sequencing (NGS) when tissue biopsy is not available. This study aims to estimate in the Spanish setting, the cost-effectiveness of using FoundationOne Liquid CDx (F1L CDx), a novel blood-derived LB test based on NGS, versus non-molecular diagnosis (non-mDx) in patients with advanced non-small cell lung cancer (NSCLC) in whom tissue sampling is not feasible. A joint model was developed combining a decision-tree with partitioned survival models to calculate the costs and health outcomes over a lifetime horizon, comparing F1L CDx in LB versus non-mDx. Only direct costs (expressed in € of 2023) were included and a 3% discount rate for future costs and effects was considered. Health outcomes were expressed in Life Years (LYs) and Quality-Adjusted Life Years (QALYs). Utilities and treatment efficacy were obtained from the literature. An expert panel of 11 Spanish oncologists determined the treatment allocation and validated all model inputs and assumptions. Several sensitivity analyses were performed to assess the robustness of the results. In a hypothetical cohort of 1,000 patients, LB using F1L CDx would detect 386 alterations, so those patients could be treated with targeted therapies or enrolled in clinical trials. Cost-effectiveness results showed that F1L CDx provides greater effectiveness than non-mDx (+383.95 LYs and +305.94 QALYs), with an additional cost of €2,898,308. The incremental cost-utility ratio was €9,473/QALY gained. The probabilistic sensitivity analysis confirmed the robustness of the cost-effectiveness results. Various limitations inherent to cost-effectiveness analyses were described. LB with F1L CDx test is a cost-effective strategy in Spain for patients with advanced NSCLC without tissue sample available for molecular diagnosis, improving the personalized treatment of these patients.
Assessment of clinical and economic impact of rivaroxaban plus aspirin vs. aspirin alone as a secondary prophylaxis in patients with chronic and symptomatic peripheral arterial disease in the United States
Creators: name: Shah, Anshul
name: Dabbous, Firas
name: Shah, Surbhi
name: Ashton, Veronica
name: Kharat, Akshay
Publisher: name: Taylor & Francis
Year: 2023
Subjects: subject: Medicine
subject: Pharmacology
subject: Sociology
subject: FOS: Sociology
subject: Biological Sciences not elsewhere classified
subject: Cancer
subject: Science Policy

description: The objective in this study was to assess the clinical and economic implications of the inclusion of rivaroxaban as a secondary prophylaxis in patients with chronic or symptomatic peripheral artery disease (PAD) in the United States (US). A cost-consequence model was adapted to evaluate the economic impact of rivaroxaban plus aspirin in a hypothetical 1-million-member health plan. The model inputs were taken from multiple sources: efficacy and safety of rivaroxaban + aspirin vs. aspirin alone were abstracted from COMPASS and VOYAGER randomized clinical trials; the prevalence of chronic and symptomatic PAD and incidence rates of clinical events (major adverse cardiac events [MACE], major adverse limb events [MALE], and major bleeding), were abstracted from the analysis of claims data; healthcare costs of clinical events and wholesale acquisition costs for rivaroxaban were abstracted from the literature and Red Book, respectively (2022 USD). One-way sensitivity analyses and subgroup analyses were also conducted. Over one year, with a 5% uptake of rivaroxaban, the model estimated rivaroxaban + aspirin to reduce 21 MACE/MALE events in the PAD patient population. The reduction in these clinical events offsets the increased risk of major bleeding (16 additional events), demonstrating a positive health benefit of the rivaroxaban addition. These benefits led to a $0.27 incremental cost per member per month (PMPM) to a US plan. The major driver of the incremental cost was the cost of rivaroxaban. In a subgroup of patients with the presence of any high-risk factor (heart failure, diabetes, renal insufficiency, or history of vascular disease affecting two or more vascular beds), the incremental PMPM cost was $0.13. Rivaroxaban + aspirin was found to provide positive net clinical benefit on the annual number of MACE/MALE avoided, with a modest increase in the PMPM cost.
Einige Nachträge zu den Bänden 1 bis 4 der "Farn- und Blütenpflanzen Baden-Württembergs"
Creators: name: Plieninger, Walter
Publisher: name: - NO PUBLISHER DEFINED -
Year: 1995

description: Jahreshefte der Gesellschaft für Naturkunde in Württemberg
description: Bd. 151, 1995
Boden- und Vegetationsveränderungen in den letzten 60 Jahren an ausgewählten Standorten im Staatswald Güglingen (Stromberg, Baden-Württemberg). (Walter-Schall-Preis 1994)
Creators: name: Riedinger, Renate
Publisher: name: - NO PUBLISHER DEFINED -
Year: 1995

description: Jahreshefte der Gesellschaft für Naturkunde in Württemberg
description: Bd. 151, 1995
title: Photon counting of extreme ultraviolet high harmonics using a superconducting nanowire single-photon detector
Creators: name: Fuchs, Silvio
name: Abel, Johann J.
name: Nathanael, Jan
name: Reinhard, Julius
name: Wiesner, Felix
name: Wünsche, Martin
name: Skruszewicz, Slawomir
name: Rödel, Christian
name: Born, Detlef
name: Schmidt, Heidemarie
name: Paulus, Gerhard G.
Publisher: name: Springer
Year: 2025

description: Laser-driven light sources in the extreme ultraviolet range (EUV) enable nanoscopic imaging with unique label-free elemental contrast. However, to fully exploit the unique properties of these new sources, novel detection schemes need to be developed. Here, we show in a proof-of-concept experiment that superconducting nanowire single-photon detectors (SNSPD) can be utilized to enable photon counting of a laser-driven EUV source based on high harmonic generation (HHG). These detectors are dark-count free and accommodate very high count rates—a perfect match for high repetition rate HHG sources. In addition to the advantages of SNSPDs for classical imaging applications with laser-driven EUV sources, the ability to count single photons paves the way for very promising applications in quantum optics and quantum imaging with high energetic radiation like, e.g., quantum ghost imaging with nanoscale resolution.
Hyboella undatifemura Deng, Zheng & Wei 2007
Creators: name: Deng, Wei-An
name: Zheng, Zhe-Min
name: Li, Xiao-Dong
name: Lin, Min-Ping
name: Wei, Shi-Zhen
name: Yuan, Bao-Dong
name: Lin, Li-Liang
Publisher: name: Zenodo
Year: 2015
Subjects: Biodiversity
Taxonomy
Animalia
Arthropoda
Insecta
Orthoptera
Tetrigidae
Hyboella
Hyboella undatifemura

description: 38. Hyboella undatifemura Deng, Zheng & Wei, 2007
Specimens examined. 4 ♂ 3♀, Fangcheng (Fulong), 21°51’N, 107°51’E, 500m alt, 26 Jul. 2012, collected by Li- Liang LIN.
Distribution. China (Guangxi).
description: Published as part of Deng, Wei-An, Zheng, Zhe-Min, Li, Xiao-Dong, Lin, Min-Ping, Wei, Shi-Zhen, Yuan, Bao-Dong & Lin, Li-Liang, 2015, The groundhopper fauna (Orthoptera: Tetrigidae) of Shiwanshan (Guangxi, China) with description of three new species, pp. 151-178 in Zootaxa 3925 (2) on page 165, DOI: 10.11646/zootaxa.3925.2.1, http://zenodo.org/record/243557
Das Vorkommen des Krautigen Backenklees (Dorycnium herbaceum VILL.) in Württemberg mit einem Ausblick auf die Vorkommen in Deutschland
Creators: name: Scheerer, Hans
Publisher: name: - NO PUBLISHER DEFINED -
Year: 1995

description: Jahreshefte der Gesellschaft für Naturkunde in Württemberg
description: Bd. 151, 1995
Cost-effectiveness analysis of budesonide/formoterol SMART therapy versus salmeterol/fluticasone plus as-needed SABA among patients ≥12 years with moderate asthma from the Chinese societal perspective
Creators: name: Zhou, Keruo
name: Zhang, Min
name: Zuo, Chenyu
name: Xie, Xiazhen
name: Jianwei
name: Xuan
Publisher: name: Taylor & Francis
Year: 2024
Subjects: subject: Medicine
subject: Pharmacology
subject: Biological Sciences not elsewhere classified
subject: Science Policy
subject: Infectious Diseases
subject: FOS: Health sciences

description: Objectives: To evaluate the cost-effectiveness of budesonide/formoterol reliever and maintenance therapy compared with salmeterol/fluticasone plus salbutamol as reliever therapy for asthma patients ≥12 years from the societal perspective in China. Methods: A Markov model was developed with three health states (non-exacerbation, exacerbation, and death) with a lifetime horizon. The exacerbation rates were obtained from a prospective cohort study conducted in Chinese asthma patients. Healthcare resources utilization data were estimated based on current clinical asthma management guidelines. Asthma-related mortality, cost input and utility values were derived from public database and literature. Model robustness was assessed with one-way sensitivity and probabilistic sensitivity analyses. Results: Compared with salmeterol/fluticasone plus salbutamol, budesonide/formoterol reliever and maintenance therapy led to fewer exacerbation events (13.6 vs. 15.9) and 0.0077 quality-adjusted life years (QALY) gain at an additional cost of ¥196.38 over lifetime. The base case incremental cost-effectiveness ratio (ICER) was ¥25,409.98 per QALY gained. The variables that had most impact on the model output included drug costs and medication adherence. At a willingness-to-pay threshold of ¥257,094/QALY (3 times of gross domestic product per capita in China in 2022), the probability of budesonide/formoterol maintenance and reliever therapy being cost-effective versus salmeterol/fluticasone plus as-needed salbutamol was 83.00%. Conclusion: From the societal perspective, budesonide/formoterol reliever and maintenance therapy is likely to be a cost-effective option compared with salmeterol/fluticasone plus as-needed salbutamol for Chinese asthma patients ≥12 years.
Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population
Creators: name: Alvarez, F.P
name: Allard, L.
name: Bianic, F.
name: Bricout, H.
name: Crépey, P.
name: Gaillat, J.
name: Gavazzi, G.
name: Mosnier, A.
name: Launay, O.
name: Levant, MC
name: Proshenska, D.
name: deCourville, C.
Publisher: name: Taylor & Francis
Year: 2024
Subjects: subject: Medicine
subject: Sociology
subject: FOS: Sociology
subject: Biological Sciences not elsewhere classified
subject: Science Policy
subject: Virology

description: Seasonal influenza outbreaks in France cause a surge in patients, exacerbating the overburdened healthcare system each winter. Older adults are particularly vulnerable to serious events related to influenza. Quadrivalent influenza high dose (QIV HD) vaccines have been developed to offer better clinical protection in older adults, who often exhibit suboptimal immune response to quadrivalent influenza standard dose vaccines (QIV SD). This study aims to evaluate the public health impact and cost-effectiveness of administering HD versus SD vaccines to individuals aged 65+ in France. Using a static model and decision-tree approach, the study analyzed health outcomes such as influenza cases, GP (general practitioner) visits, hospitalizations, and mortality; relative vaccine efficacy (rVE) estimates were derived from a pivotal randomized-controlled trial and a meta-analysis comparing HD to SD vaccines. Two approaches were implemented to model hospitalizations (conditional on influenza or not), and analyses on bed occupancy were performed. Results showed that using QIV HD instead of QIV SD during an average influenza season in France led to the prevention of 57,209 additional cases of influenza, 13,704 GP visits, and 764 influenza-related deaths. Moreover, switching to QIV HD resulted in additional 1,728 to 15,970 hospitalizations avoided and 15,124 to 138,367 reduced days of hospitalization depending on the hospitalization approach used. The cost-utility analysis showed a cost per quality-adjusted life year (QALY) gained ranging from 24,020 €/QALY to 5,036 €/QALY. Switching to QIV HD in older adults showed to be cost-effective, with even greater public health benefits at higher coverage rate, regardless the season severity.
Additional tables and figures from Parasite spillover rather than niche expansion explains infection of host brain by diplostomid eye flukes
Creators: name: Diaz-Suarez, Alfonso
name: Kisand, Veljo
name: Kahar, Siim
name: Gross, Riho
name: Vasemägi, Anti
name: Noreikiene, Kristina
Publisher: name: The Royal Society
Year: 2024
Subjects: classificationCode: 310499
subject: Evolutionary biology not elsewhere classified

description: This file includes two tables with the primers used in the quadruple-indexed target-specific metabarcoding. A separate table with the taxonomic assignation of the ASVs. The outputs of the corrected Akaike â€˜s Information Criterion for all models and additional models with alternatives data distribution.
Additional file 2: of Meeting report: the 5th International expert symposium in Fukushima on radiation and health
Creators: name: Saenko, Vladimir
name: Thomas, Geraldine
name: Yamashita, Shunichi
Publisher: name: Figshare
Year: 2017
Subjects: subject: Biophysics
subject: 29999 Physical Sciences not elsewhere classified
subject: FOS: Physical sciences
subject: Medicine
subject: Cell Biology
subject: Molecular Biology
subject: Biotechnology
subject: Sociology
subject: FOS: Sociology
subject: Developmental Biology
subject: Cancer
subject: Science Policy
subject: Hematology

description: Chairpersons and speakers of the 5th International expert symposium in Fukushima on radiation and health (in alphabetical order). (DOC 42Â kb)